Investec's shares fell about 8% on 19 November 2026 — to around 550p — on a day it reported adjusted operating profit up 5.6% to £494.5m, adjusted earnings per share up 7.4% to 43.5p and a higher interim dividend of 18.5p. The number that did the damage was none of those. Operating costs grew 9.7% against revenue growth of 6.7%, pushing the cost-to-income ratio to 53.3% from 51.9% a year earlier. An 8% de-rating on a profit rise and a dividend increase is not a verdict on earnings; it is a verdict on where those earnings came from and what they cost to produce.
Any Investec fundamental analysis has to start there, because the divisional split is more revealing than the group total. UK and Other adjusted operating profit fell 2.7% to £223.9m, with its return on tangible equity dropping to 12.7% from 13.6%. Southern Africa rose 13.6% to £270.6m, with a segment ROTE of 19.1% against 18.5%. In other words, the entire increase in group profit came from the South African business, helped by a strong rand, while the UK bank went backwards. The group still produced a 13.5% return on equity and a 15.5% ROTE — the latter down slightly from 15.7% — and management held full-year guidance, but the market has concluded that roughly half the earnings base is translated from another currency and the other half has lost its operating leverage. On a tangible net asset value of 571.2p per share, the post-results price of around 550p puts the stock at roughly 0.96 times tangible book.
What actually happened
Investec plc published interim results for the six months to 30 September 2026 by RNS on 19 November 2026. The group headlines were solid. Adjusted operating profit of £494.5m compared with £468.1m in the prior period, a rise of 5.6%. Adjusted EPS rose 7.4% to 43.5p — ahead of profit growth, reflecting the effect of buybacks on the share count. The board proposed an interim dividend of 18.5p against 17.5p, a payout ratio of 42.5%.
Revenue growth was unusually uniform: net interest income, non-interest revenue and total revenue each grew 6.7%. That symmetry matters, because it means the cost problem is genuinely a cost problem rather than a mix shift. Operating costs grew 9.7%, which management attributed to investment in client-facing roles, technology, regulatory projects and general inflation. The resulting 53.3% cost-to-income ratio sits inside the company's own full-year guidance range of 52.0%-54.0%, but at the wrong end of it, and 140 basis points worse than a year ago.
The divisional detail:
- UK and Other: adjusted operating profit down 2.7% to £223.9m. ROTE 12.7%, down from 13.6%. Within this, Specialist Banking UK and Other fell 3.9% to £192.4m; Wealth & Investment UK and Other rose, principally on the contribution from the group's stake in Rathbones.
- Southern Africa: adjusted operating profit up 13.6% to £270.6m, driven by lending book growth and lower funding costs. Segment ROTE 19.1%, up from 18.5%.
The balance sheet was the quiet strength of the release. The group credit loss ratio improved to 28 basis points from 36bps at 31 March 2026, comfortably inside the 25-45bps through-the-cycle range, with expected credit loss impairment charges of £51.2m. Net asset value per share rose 3.1% to 656.3p, and tangible net asset value per share grew 8.2% to 571.2p. Investec plc reported a CET1 ratio of 13.1% on the standardised approach; Investec Limited reported 13.8% on the advanced internal ratings-based approach, down from 14.6% a year earlier. Investec Bank plc, a subsidiary, reported a separate annualised credit loss ratio of 51bps, which should not be confused with the group figure.
Management reiterated full-year guidance of a group return on equity between 13.0% and 14.0% for the year to March 2027, and a cost-to-income ratio of 52.0%-54.0%. The group also finalised its partnership with Shoprite in South Africa.
Why the market reacted the way it did
A pre-close statement had already flagged that the UK business would deliver a ROTE between 12.3% and 12.7%. The reported 12.7% therefore landed at the top of a range the company had already warned about — and the shares still fell 8%. That tells you the reaction was not about a miss against guidance. It was about the composition of the result being confirmed rather than disproved.
Three things drove the de-rating. First, jaws reversed. Costs growing 9.7% against revenue at 6.7% is a 300 basis point negative gap, and for a bank that is the clearest single indicator of operating leverage breaking down. Investors will tolerate investment spending when it is accompanied by accelerating revenue; here revenue growth was steady and unremarkable.
Second, the geographic concentration of the growth. Southern Africa contributed more than the entire group increase, and did so with the help of a strong rand. Translation gains are real money but they are not franchise progress, and they reverse. A London-listed investor buying Investec for its specialist banking franchise discovered that the franchise growing is the one in Johannesburg.
Third, the UK decline was in the core. Specialist Banking UK and Other — the lending business, the part that should compound — fell 3.9% to £192.4m. The UK division was held up by Wealth & Investment, and within that largely by the Rathbones stake, which is an associate holding rather than operating momentum.
Reported share moves varied with the venue and the timing: around 7.8% on one measure, 8% to approximately 553p on another, and 8.88% to 546.28p by mid-morning in London on a third. The South African listing was down a lesser 5.7%, which is itself consistent with the read that the problem is the UK half of the business.
The Openbook read
Profitability is the factor doing the work here, and it should be scored on the divisional ROTEs rather than the group figure. A 15.5% group ROTE looks healthy; it is an average of a 19.1% South African business and a 12.7% UK business, and the UK number has fallen for the reason that matters — costs, not credit. The group ROE of 13.5% sits inside the 13.0%-14.0% full-year guidance, so nothing is broken, but the trajectory within the guidance range is downward and the cost-to-income ratio is at the unhelpful end of its band.
Growth is flattered and should be discounted. Reported adjusted EPS growth of 7.4% is partly a buyback artefact and partly a currency one. Strip the rand tailwind and the UK decline out, and the underlying franchise growth rate is materially lower than the headline suggests. Revenue growing 6.7% across all three lines is the honest number.
Solvency scores well and is the most underappreciated part of this release. A credit loss ratio of 28bps, improving from 36bps and sitting below the midpoint of the 25-45bps through-the-cycle range, is a strong outcome at this point in the UK credit cycle. ECL charges of £51.2m against nearly £500m of adjusted operating profit means credit is not currently a constraint. Tangible NAV per share compounding 8.2% to 571.2p is the clean measure of value accretion and it comfortably exceeded the share price performance.
Momentum is poor and now has a confirmed cause. The shares have de-rated on a result that met the company's own pre-close steer, which means the market has repriced the quality of the earnings rather than reacted to a surprise. That is harder to reverse than a one-off miss, because it requires several halves of UK cost discipline to disprove.
Reward/Risk is the interpretive edge, and it comes down to what a buyer at around 0.96 times tangible book is actually buying. Roughly half the group's earnings are translated from rand, so part of the position is a currency exposure dressed as a London-listed specialist bank — a point that cuts favourably when the rand is strong, as it was this half, and against when it is not. The other half is a UK franchise where operating leverage has broken and the fix is management-controlled but slow. The offsetting strength is that none of this is a credit story: impairments improved, capital is adequate and tangible book is compounding faster than earnings. A reader should weigh a cheap-looking multiple against the fact that the cheapness is attached to the half of the business that is not currently growing. Compare the profile against other UK specialist lenders and wealth managers on our screener, or review the factor history on the INVP equity page.
The read-across
For UK specialist banking peers the signal is specific and worth taking seriously: revenue is growing, credit is behaving, and costs are the binding constraint. Investec's 9.7% cost growth was attributed to client-facing hires, technology and regulatory projects — none of which is idiosyncratic. Any lender running a similar investment programme into a mid-single-digit revenue environment faces the same jaws arithmetic, and Investec has now demonstrated that the market will punish it even when guidance is met. Names such as Close Brothers sit in the same flow.
For wealth managers, the Rathbones contribution cuts the other way. Wealth & Investment was the part of Investec's UK division that grew, and the associate stake in Rathbones was the principal reason. That is a datapoint in favour of the scale consolidation thesis in UK wealth management, where cost synergies from combination are the main lever available.
For the dual-listed cohort more broadly — the London-quoted companies whose earnings are substantially generated in emerging markets — Investec is a clean illustration of a recurring problem. A strong local currency produces a flattering headline that the market discounts, and a weak one produces the reverse. The group's own disclosure of divisional ROTEs is what allows investors to see through it; companies that report only group aggregates give no such opportunity.
What to watch next
- 1 January 2027 — the Basel output floor step-up. This is the most specific and most overlooked item in the release. The prescribed output floor increases to 70%, which Investec expects to reduce Investec Limited's CET1 ratio by a further 85-100 basis points. The floor already cost 28bps at this reporting date. With Investec Limited's CET1 at 13.8% and already down from 14.6%, this is a known, dated capital headwind.
- Full-year results for the year to 31 March 2027, due in May 2027. The tests are whether the cost-to-income ratio closes back towards 52% from 53.3%, and whether group ROE lands in the upper or lower half of the 13.0%-14.0% guidance range.
- UK and Other ROTE. Having fallen from 13.6% to 12.7%, this is the single number that determines whether the de-rating was fair. Stabilisation would require UK cost growth to fall below UK revenue growth.
- Specialist Banking UK lending momentum. A 3.9% decline to £192.4m in the core lending business is the problem the Wealth division is currently masking. Watch whether loan book growth returns.
- The rand. With Southern Africa providing more than the whole of the group's profit increase, currency is now a first-order variable for reported earnings rather than a footnote.
- Credit loss ratio against the 25-45bps range. At 28bps there is room for normalisation to absorb some of the cost pressure's impact on returns — or to add to it if UK credit turns.
Discussion
Log in to join the discussion